PRNP and Alzheimer disease: With the development of experimental therapeutics targeting amyloid-β in Alzheimer's disease (AD) (Salloway et al., 2009) or prion protein in prion disease (Nicoll and Collinge, 2009), diagnosis of dementia in the earliest stages is becoming increasingly important (Burns and Iliffe, 2009).